137 computer-programmer-"the"-"U"-"UCL"-"FEMTO-ST-institute" "Prof" PhD positions at DAAD
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
is limited for three years. Description of the project The research group of Prof. Dr. Dr. h.c. Frank Schreiber at the University of Tübingen works on the physics of molecular and biological matter
-
, including a structured PhD project plan, international exchange, and a dedicated Thesis Advisory Committee (TAC) mentorship via the REC² mentoring board TUD strives to employ more women in academia and
-
-Aware Artificial Intelligence (Prof. Dr. Simon Razniewski) Research area: Exploring the potential of LLM-supported mobility planning This position is offered in collaboration with the Collaborative
-
space that facilitates collaboration across diverse disciplines and methodologies, as well as the application of AI-based concepts. To address this, we plan to implement a sustainable research data
-
researchers, who are willing to provide reference letters. Please submit your application by January 15, 2026. If you have any questions, please contact Prof. Dr. Sarah Köster ( sarah.koester at uni
-
at the host-virus interface. Our central methodologies are solution NMR, crystallography and SAXS, together with a broad method spectrum from biochemistry and biophysics. In this project, we plan to analyze
-
to combine ribonucleic acid (RNA) research with infection biology. Based on novel findings from our strong basic research program, our long-term goal is to develop innovative therapeutic approaches to better
-
serves to support a doctoral programme. The position is temporary for the duration of the doctoral process, but initially up to 3 years. An extension for the completion of the doctorate is possible within
-
the reference number “SKE” in the subject of your mail. Please contact Prof. Dr. Christian Kost (email: christian.kost@uni-osnabrueck.de ) with any question regarding the position and check the website
-
to combine ribonucleic acid (RNA) research with infection biology. Based on novel findings from our strong basic research program, our long-term goal is to develop innovative therapeutic approaches to better